These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 11054765

  • 1. The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment.
    Lawford BR, Young RM, Noble EP, Sargent J, Rowell J, Shadforth S, Zhang X, Ritchie T.
    Am J Med Genet; 2000 Oct 09; 96(5):592-8. PubMed ID: 11054765
    [Abstract] [Full Text] [Related]

  • 2. Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments.
    Barratt DT, Coller JK, Somogyi AA.
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun 05; 141B(4):323-31. PubMed ID: 16583408
    [Abstract] [Full Text] [Related]

  • 3. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S, Besson J, Croquette-Krokar M, Hämmig R, Gothuey I, Monnat M, Déglon JJ, Preisig M, Eap CB.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct 01; 32(7):1722-7. PubMed ID: 18687376
    [Abstract] [Full Text] [Related]

  • 4. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО, Krupitsky ЕМ, Blokhina ЕА, Verbitskaya ЕV, Brodyansky VМ, Alekseeva NP, Bushara NМ, Yaroslavtseva ТS, Palatkin VY, Masalov DV, Burakov АМ, Romanova ТN, Sulimov GY, Grinenko AY, Kosten Т, Nielsen D, Zvartau EE.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016 Oct 01; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [Abstract] [Full Text] [Related]

  • 5. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
    Bawor M, Dennis BB, Tan C, Pare G, Varenbut M, Daiter J, Plater C, Worster A, Marsh DC, Steiner M, Anglin R, Desai D, Thabane L, Samaan Z.
    Addict Sci Clin Pract; 2015 Oct 06; 10():19. PubMed ID: 26437921
    [Abstract] [Full Text] [Related]

  • 6. [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].
    Duan LX, Li XL, Hu PW, Luo R, Luo X, Chen YY.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb 10; 39(2):194-198. PubMed ID: 29495204
    [Abstract] [Full Text] [Related]

  • 7. Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients.
    Huang MW, Chiang TA, Lo PY, Huang CS.
    Behav Brain Funct; 2016 Aug 31; 12(1):24. PubMed ID: 27580593
    [Abstract] [Full Text] [Related]

  • 8. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
    Fonseca F, Gratacòs M, Escaramís G, De Cid R, Martín-Santos R, Fernández-Espejo E, Estivill X, Torrens M.
    Mol Diagn Ther; 2010 Jun 01; 14(3):171-8. PubMed ID: 20560679
    [Abstract] [Full Text] [Related]

  • 9. Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies.
    Chen D, Liu F, Shang Q, Song X, Miao X, Wang Z.
    Am J Med Genet B Neuropsychiatr Genet; 2011 Sep 01; 156B(6):661-70. PubMed ID: 21714067
    [Abstract] [Full Text] [Related]

  • 10. The polymorphism of dopamine D2 receptor TaqIA gene is associated with brain response to drug cues in male heroin-dependent individuals during methadone maintenance treatment.
    Li Y, Li Q, Li W, Chen J, Hu F, Liu Y, Wei X, Zhu J, Liu J, Ye J, Shi H, Wang Y, Wang W.
    Drug Alcohol Depend; 2019 May 01; 198():150-157. PubMed ID: 30928885
    [Abstract] [Full Text] [Related]

  • 11. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
    Doehring A, Hentig Nv, Graff J, Salamat S, Schmidt M, Geisslinger G, Harder S, Lötsch J.
    Pharmacogenet Genomics; 2009 Jun 01; 19(6):407-14. PubMed ID: 19373123
    [Abstract] [Full Text] [Related]

  • 12. Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects.
    Li T, Liu X, Zhao J, Hu X, Ball DM, Loh el-W, Sham PC, Collier DA.
    Am J Med Genet; 2002 Apr 08; 114(3):329-35. PubMed ID: 11920858
    [Abstract] [Full Text] [Related]

  • 13. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence.
    Randesi M, van den Brink W, Levran O, Blanken P, Butelman ER, Yuferov V, da Rosa JC, Ott J, van Ree JM, Kreek MJ.
    Drug Alcohol Depend; 2016 Nov 01; 168():164-169. PubMed ID: 27664554
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D2 receptor gene polymorphisms in newborn infants of drug-using women.
    Oei JL, Xu HX, Abdel-Latif ME, Vunnam K, Al-Amry A, Clews S, Falconer J, Feller JM, Lui K.
    Arch Dis Child Fetal Neonatal Ed; 2012 May 01; 97(3):F193-8. PubMed ID: 21948329
    [Abstract] [Full Text] [Related]

  • 15. Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese.
    Gao X, Wang Y, Lang M, Yuan L, Reece AS, Wang W.
    OMICS; 2017 Jul 01; 21(7):404-412. PubMed ID: 28692418
    [Abstract] [Full Text] [Related]

  • 16. Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.
    Chen TJ, Blum K, Payte JT, Schoolfield J, Hopper D, Stanford M, Braverman ER.
    Med Hypotheses; 2004 Jul 01; 63(3):538-48. PubMed ID: 15288384
    [Abstract] [Full Text] [Related]

  • 17. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J, Verthein U, Karow A, Schäfer I, Naber D, Haasen C.
    Addiction; 2011 Sep 01; 106(9):1647-55. PubMed ID: 21489005
    [Abstract] [Full Text] [Related]

  • 18. β-Arrestin2 influences the response to methadone in opioid-dependent patients.
    Oneda B, Crettol S, Bochud M, Besson J, Croquette-Krokar M, Hämmig R, Monnat M, Preisig M, Eap CB.
    Pharmacogenomics J; 2011 Aug 01; 11(4):258-66. PubMed ID: 20514076
    [Abstract] [Full Text] [Related]

  • 19. Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study.
    Perez de los Cobos J, Baiget M, Trujols J, Sinol N, Volpini V, Banuls E, Calafell F, Luquero E, del Rio E, Alvarez E.
    Behav Brain Funct; 2007 Jun 01; 3():25. PubMed ID: 17543096
    [Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ.
    Arch Gen Psychiatry; 2006 Jan 01; 63(1):102-9. PubMed ID: 16389204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.